Your browser doesn't support javascript.
loading
Subcortical brain structure and suicidal behaviour in major depressive disorder: a meta-analysis from the ENIGMA-MDD working group.
Rentería, M E; Schmaal, L; Hibar, D P; Couvy-Duchesne, B; Strike, L T; Mills, N T; de Zubicaray, G I; McMahon, K L; Medland, S E; Gillespie, N A; Hatton, S N; Lagopoulos, J; Veltman, D J; van der Wee, N; van Erp, T G M; Wittfeld, K; Grabe, H J; Block, A; Hegenscheid, K; Völzke, H; Veer, I M; Walter, H; Schnell, K; Schramm, E; Normann, C; Schoepf, D; Konrad, C; Zurowski, B; Godlewska, B R; Cowen, P J; Penninx, B W J H; Jahanshad, N; Thompson, P M; Wright, M J; Martin, N G; Christensen, H; Hickie, I B.
Afiliación
  • Rentería ME; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Schmaal L; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Hibar DP; Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Couvy-Duchesne B; Imaging Genetics Center, Department of Neurology, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
  • Strike LT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Mills NT; Queensland Brain Institute, University of Queensland, Brisbane, QLD, Australia.
  • de Zubicaray GI; Center for Advanced Imaging, University of Queensland, Brisbane, QLD, Australia.
  • McMahon KL; Queensland Brain Institute, University of Queensland, Brisbane, QLD, Australia.
  • Medland SE; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Gillespie NA; Queensland Brain Institute, University of Queensland, Brisbane, QLD, Australia.
  • Hatton SN; Faculty of Health and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia.
  • Lagopoulos J; Center for Advanced Imaging, University of Queensland, Brisbane, QLD, Australia.
  • Veltman DJ; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • van der Wee N; Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, USA.
  • van Erp TGM; Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.
  • Wittfeld K; Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.
  • Grabe HJ; Department of Psychiatry and Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Block A; Department of Psychiatry, Leiden University Medical Center, Leiden University, Leiden, The Netherlands.
  • Hegenscheid K; Leiden Institute for Brain and Cognition, Leiden, The Netherlands.
  • Völzke H; Department of Psychiatry and Human Behavior, University of California, Irvine, CA, USA.
  • Veer IM; German Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Germany.
  • Walter H; German Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Germany.
  • Schnell K; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
  • Schramm E; Sociology of Health and Physical Activity, Department of Health Science, University of Potsdam, Potsdam, Germany.
  • Normann C; Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
  • Schoepf D; Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
  • Konrad C; Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Zurowski B; Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Godlewska BR; Department of General Psychiatry, University Hospital Heidelberg, Heidelberg, Germany.
  • Cowen PJ; Department of Psychiatry and Psychotherapy, University Medical Center Freiburg, Freiburg, Germany.
  • Penninx BWJH; Psychiatric University Clinic, Basel, Switzerland.
  • Jahanshad N; Department of Psychiatry and Psychotherapy, University Medical Center Freiburg, Freiburg, Germany.
  • Thompson PM; Department of Psychiatry, University of Bonn, Bonn, Germany.
  • Wright MJ; Department of Psychiatry and Psychotherapy, Agaplesion Diakoniklinikum, Rotenburg, Germany.
  • Martin NG; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Christensen H; Center for Integrative Psychiatry, University of Lübeck, Lübeck, Germany.
  • Hickie IB; University Department of Psychiatry, Warneford Hospital, Oxford, UK.
Transl Psychiatry ; 7(5): e1116, 2017 05 02.
Article en En | MEDLINE | ID: mdl-28463239
ABSTRACT
The aetiology of suicidal behaviour is complex, and knowledge about its neurobiological mechanisms is limited. Neuroimaging methods provide a noninvasive approach to explore the neural correlates of suicide vulnerability in vivo. The ENIGMA-MDD Working Group is an international collaboration evaluating neuroimaging and clinical data from thousands of individuals collected by research groups from around the world. Here we present analyses in a subset sample (n=3097) for whom suicidality data were available. Prevalence of suicidal symptoms among major depressive disorder (MDD) cases ranged between 29 and 69% across cohorts. We compared mean subcortical grey matter volumes, lateral ventricle volumes and total intracranial volume (ICV) in MDD patients with suicidal symptoms (N=451) vs healthy controls (N=1996) or MDD patients with no suicidal symptoms (N=650). MDD patients reporting suicidal plans or attempts showed a smaller ICV (P=4.12 × 10-3) or a 2.87% smaller volume compared with controls (Cohen's d=-0.284). In addition, we observed a nonsignificant trend in which MDD cases with suicidal symptoms had smaller subcortical volumes and larger ventricular volumes compared with controls. Finally, no significant differences (P=0.28-0.97) were found between MDD patients with and those without suicidal symptoms for any of the brain volume measures. This is by far the largest neuroimaging meta-analysis of suicidal behaviour in MDD to date. Our results did not replicate previous reports of association between subcortical brain structure and suicidality and highlight the need for collecting better-powered imaging samples and using improved suicidality assessment instruments.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Imagen por Resonancia Magnética / Trastorno Depresivo Mayor / Ideación Suicida / Neuroimagen Tipo de estudio: Etiology_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transl Psychiatry Año: 2017 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Imagen por Resonancia Magnética / Trastorno Depresivo Mayor / Ideación Suicida / Neuroimagen Tipo de estudio: Etiology_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transl Psychiatry Año: 2017 Tipo del documento: Article País de afiliación: Australia
...